Free Trial

Sharecare (SHCR) Stock Forecast & Price Target

0.00 (0.00%)
(As of 07/12/2024 ET)

Sharecare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

4.00% Upside
High Forecast$1.43
Average Forecast$1.43
Low Forecast$1.43
TypeCurrent Forecast
7/14/23 to 7/13/24
1 Month Ago
6/14/23 to 6/13/24
3 Months Ago
4/15/23 to 4/14/24
1 Year Ago
7/14/22 to 7/14/23
Consensus Rating
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
4 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$1.43$1.50N/A$3.03
Forecasted Upside4.00% Upside87.49% UpsideN/A67.59% Upside
Get Sharecare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SHCR and its competitors with MarketBeat's FREE daily newsletter.

SHCR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SHCR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sharecare Stock vs. The Competition

TypeSharecareMedical CompaniesS&P 500
Consensus Rating Score
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside4.00% Upside994.21% Upside9.17% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/24/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$1.00 ➝ $1.43+4.38%
6/21/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Close
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/1/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
9/21/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$1.50 ➝ $2.10+6.06%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:55 AM ET.

SHCR Forecast - Frequently Asked Questions

What is Sharecare's forecast for 2024?

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Sharecare is $1.43, with a high forecast of $1.43 and a low forecast of $1.43.

Should I buy or sell Sharecare stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sharecare in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SHCR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SHCR, but not buy additional shares or sell existing shares.

Does Sharecare's stock price have much upside?

According to analysts, Sharecare's stock has a predicted upside of 4.38% based on their 12-month stock forecasts.

Has Sharecare been downgraded by Wall Street analysts recently?

Over the previous 90 days, Sharecare's stock had 1 downgrade by analysts.

What analysts cover Sharecare?

Sharecare has been rated by research analysts at Canaccord Genuity Group, Canaccord Genuity Group, and Morgan Stanley in the past 90 days.

Do Wall Street analysts like Sharecare more than its competitors?

Analysts like Sharecare less than other "medical" companies. The consensus rating for Sharecare is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SHCR compares to other companies.

This page (NASDAQ:SHCR) was last updated on 7/13/2024 by Staff

From Our Partners